Abstract

Synthetic amorphous silica is used in various applications such as cosmetics, food, or rubber reinforcement. These broad uses increase human exposure, and thus the potential risk related to their short- and long-term toxicity for both consumers and workers. These potential risks have to be investigated, in a global context of multi-exposure, as encountered in human populations. However, most of the in vitro research on the effects of amorphous silica has been carried out in an acute exposure mode, which is not the most relevant when trying to assess the effects of occupational exposure. As a first step, the effects of repeated exposure of macrophages to silica nanomaterials have been investigated. The experiments have been conducted on in vitro macrophage cell line RAW264.7 (cell line from an Abelson murine leukemia virus-induced tumor), as this cell type is an important target cell in toxicology of particulate materials. The bioaccumulation of nanomaterials and the persistence of their effects have been studied. The experiments carried out include the viability assay and functional tests (phagocytosis, NO and reactive oxygen species dosages, and production of pro- and anti-inflammatory cytokines) using flow cytometry, microscopy and spectrophotometry. Accumulation of silica nanoparticles (SiO2 NP) was observed in both exposure scenarii. However, differences in the biological effects between the exposure scenarii have also been observed. For phagocytosis, NO production and Tumor Necrosis Factor (TNF) release, repeated exposure tended to induce fewer effects than acute exposure. Nevertheless, repeated exposure still induces alterations in the macrophage responses and thus represents a scenario to be tested in detail.

Highlights

  • Silica nanoparticles SiO2NP are used in many applications such as cosmetics, food or rubber reinforcement [1,2]

  • Its primary particle is a nanoparticle (NP) of ~20 nm in diameter, E551 occurs in clusters of micrometer size, which is similar to the fumed silica but does not contain crystalline domains, and the ingested dose is estimated to 35 mg per day [6]

  • The SiO2 NPs are accumulated by the macrophages and change the adhesion properties of the cells

Read more

Summary

Introduction

Silica nanoparticles SiO2NP are used in many applications such as cosmetics, food or rubber reinforcement [1,2]. The precipitated silica, which is produced by a wet route in a solvent, is used as a rubber reinforcing agent and as cleaning and polishing agent in toothpastes [3]. It is used as an anti-caking agent in food and pharmaceutical additives [4]. Its primary particle is a nanoparticle (NP) of ~20 nm in diameter, E551 occurs in clusters of micrometer size, which is similar to the fumed silica but does not contain crystalline domains, and the ingested dose is estimated to 35 mg per day [6]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.